Delivery Order SPE2DB20D3103-SPE2DB21FQ4J7
Award Date
9/24/21
Potential Completion Date
9/27/21
Potential Value
$20K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $31,918.83 firm fixed-price delivery order is for the supply of 4,561,095,151 units of the medication Remicade (infliximab) 100 mg vials. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 100 mg Remicade vials. The contract has a firm fixed price of $27,188.48 and a completion date of December 15, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as the primary vehicle...
This federal contract award, valued at $17,086.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Remicade 100 mg vials, a specialty medication used in the treatment of various medical conditions. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp for the delivery of Remicade 100 mg vials. The $11,943.91 firm fixed-price contract has an ultimate completion date of July 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this delivery order. The contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,426.82, is for the delivery of Remicade 100 mg vials, a specialty medication. The contract has an ultimate completion date of November 13, 2024 and is structured as a Firm Fixed Price Delivery Order. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,058.97 firm-fixed-price delivery order is for the supply of REMICADE 100 mg vials, a specialty medication. The contract has an ultimate completion date of May 23, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of REMICADE 100 MG VIALS. The $75,150.30 delivery order contract is a firm fixed-price arrangement with an ultimate completion date of September 16, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to...
This federal contract award, valued at $14,536.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566598452 REMICADE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of December 4, 2024 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,640.36 delivery order is for the supply of Remicade 100 mg vials, a specialty medication used to treat various autoimmune conditions. The contract has a ceiling value of $5,640.36 and an ultimate completion date of September 15, 2022. This award is a child contract under a larger Indefinite Delivery Contract...
This federal contract award, valued at $34,273.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Remicade 100 mg vials, a specialty medication used for various therapeutic applications. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...